To this end, we determined the intracellular concentration of cAMP in T98G human glioblastoma cells treated with Bdk, which stimulates and inhibits cAMP production through Gs- and Gi-mediated pathways, respectively (7, 8). Here, KNG1 is linked to glioblastoma.